Microbiome in Neurological Conditions, Volume 180, the latest release in the International Review of Neurobiology series, highlights advances in the field, with this volume presenting insightful chapters written by an international board of authors. Chapters in this volume include Dysbiosis significantly elevates the probability of altered affective function in Alzheimer's Disease (AD), Intestinal Dysbiosis leads to reduction in Neurochemical production in Parkinson’s Disease (PD), Microbiota dysbiosis impact on the immune system dysregulation in Huntington's disease (HD), Altered microbiome influence on the enteric neuromuscular system in Amyotrophic Lateral Sclerosis (ALS), Oro-pharyngeal mucosal microbiome alterations causing immune system dysregulation in Schizophrenia, and much more.

Other chapters cover Disruption in the human microbiome causing behavioral changes in Bipolar Disorder, The role of Microbiome in Gut-Brain-Axis dysbiosis causing Depression: from Mechanisms to Treatment, Microbial imprints: The role of secondary genomes in neurodevelopment and co-evolutionary dynamics, Abnormal microbiota due to perinatal antibiotic exposure as a possible risk factor for Attention-Deficit / Hyperactivity Disorder (ADHD), Microbiome-based dietary supplements for better development and a healthy brain, Bacterial meningitis as a significant catalyst for neuroinflammation, and more.

• Provides the authority and expertise of leading contributors from an international board of authors
• Presents the latest release in the International Review on Neurobiology series
• Includes updated information on Microbiome in Neurological Conditions